Kromek Group Shares Jump: Anticipates Significant Revenue Surge in H1

Kromek Group plc (LON: KMK) has announced that it expects a substantial increase in revenue for the first half of fiscal year 2026, signaling a period of strong growth for the global detection technology company.

The pre-close trading statement, released on October 27, 2025, has instilled confidence in the board that the full-year results will meet market expectations.

Revenue for H1 2026 is projected to reach at least £14.5 million, a considerable leap from the £3.7 million reported in H1 2025.

A significant portion of this growth is attributed to the enablement agreement with Siemens Healthineers, which is expected to generate at least £8.2 million in revenue during the period.

Excluding the Siemens Healthineers contribution, Kromek anticipates underlying revenue of at least £6.3 million, marking a 70% increase compared to the £3.7 million recorded in the first half of the previous year.

The company said its organic growth is fueled by robust performance in the CBRN (Chemical, Biological, Radiological, and Nuclear) Detection division, coupled with increased underlying revenue in the Advanced Imaging division.

The surge in revenue, coupled with anticipated improvements in gross margin due to the Siemens Healthineers agreement, is expected to drive profitability. Kromek forecasts reporting profit before tax and positive adjusted EBITDA for H1 2026, a significant turnaround from the loss before tax of £5.7 million and an adjusted EBITDA loss of £2.3 million in H1 2025.

This financial turnaround underscores the effectiveness of Kromek's strategic initiatives and its ability to capitalize on growing demand in its key markets.

Kromek Group shares jumped more than 6% in early Monday trading following the news.